井寺制药(IDRA)

美东时间 2011-08-11 21:30 Q2 2011 Idera Pharmaceuticals Inc Earnings Release

美东时间 2011-06-29 22:30 Idera Pharmaceuticals Inc at Biotechnology Industry Organization International Convention

当期报告

$井寺制药(IDRA)$ 8-K Current report, items 5.03, 7.01, 8.01, and 9.01 Accession Number: 0001104659-23-004326  Act: 34  Size: 780 KB 网页链接

当期报告

$井寺制药(IDRA)$ 8-K Current report, items 5.02, 5.07, and 9.01 Accession Number: 0001104659-23-003629  Act: 34  Size: 375 KB 网页链接

持股变动声明

$井寺制药(IDRA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-23-000919  Size: 4 KB 网页链接

当期报告

$井寺制药(IDRA)$ 8-K Current report, item 8.01 Accession Number: 0001104659-23-002936  Act: 34  Size: 199 KB 网页链接

持股变动声明

$井寺制药(IDRA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-23-000764  Size: 6 KB 网页链接

持股变动声明

$井寺制药(IDRA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-23-000765  Size: 6 KB 网页链接

持股变动声明

$井寺制药(IDRA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-23-000766  Size: 6 KB 网页链接

员工持股计划

$井寺制药(IDRA)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001104659-22-129602  Act: 33  Size: 154 KB 网页链接

当期报告「修正」

$井寺制药(IDRA)$ 8-K/A [Amend] Current report, items 8.01 and 9.01 Accession Number: 0001104659-22-125903  Act: 34  Size: 228 KB 网页链接

股东委托书协议

$井寺制药(IDRA)$ DEF 14A Other definitive proxy statements Accession Number: 0001104659-22-125528  Act: 34  Size: 5 MB 网页链接